Technical Advisory Council

PETER J.HOTEZ, MD, PhD

Chair, The END Fund Technical Advisory Council

President, Sabin Vaccine Institute
Founding Dean of the National School of Tropical Medicine at Baylor College of Medicine
Editor-in-Chief of PLoS Neglected Tropical Diseases

"NTDs represent the major stealth cause of poverty among the poorest people in developing nations. The END Fund is a vital, new, cost-effective, and cost-efficient mechanism to involve the private sector in lifting the 'bottom billion' out of poverty."

ALAN FENWICK, PhD, OBE

Director, Schistosomiasis Control Initiative
Professor, Tropical Parasitology at Imperial College London

"Bilateral and multilateral supporters of NTD control don’t give individuals the chance to make a direct impact. Nor do they have the flexibility to respond to complex situations in the way the END Fund can. That’s why I am proud to be a part of it."

DANNY HADDAD, MD

Assistant Professor, Ophthalmology and Global Health
Director, Global Ophthalmology Emory

"The world has a real possibility of eliminating blinding trachoma by 2020. We've got a global strategy in place, the tools in hand, and tremendous commitment. That same feeling of collaboration and dedication is what makes the END Fund such an exciting endeavor."

ADRIAN HOPKINS, MD

Director, Mectizan® Donation Program

"Getting drugs donated is the easy part. It’s getting them into the mouths of people who need them that’s difficult. That is where the END Fund comes in, ensuring that drugs like Mectizan® reach those most in need, often neglected populations with virtually no income, no healthcare, and no political voice."

JULIE JACOBSON, MD, DMTH

Senior Program Officer, Neglected Infectious Diseases,
The Bill & Melinda Gates Foundation

"There is a role for 50 cents. Fifty cents from one person can treat a person for one year for all of these diseases, so there is a way that everybody can be a part of the NTD success and solution."

PATRICK LAMMIE, PhD

Senior Staff Scientist, Centers for Disease Control and Prevention

"As someone who has worked on lymphatic filariasis in Haiti for many years, I have a strong appreciation for the challenges countries face in mobilizing resources for NTD programs. The END Fund provides a new and flexible mechanism to help countries successfully implement high-impact programs."